Our history
Oslo Cancer Cluster was initiated in 2006 by Kaare Norum, former Principal of the University of Oslo and Jónas Einarsson, CEO of Radforsk.
In 2006, Kaare Norum, former Principal of the University of Oslo and Jónas Einarsson, CEO of Radforsk, realised that a natural cluster within oncology had developed around the Norwegian Radium Hospital. By initiating a cluster member organisation, Norum and Einarsson wanted to accelerate the ongoing collaborations and stimulate even more commercialisation. In 2007, they succeeded with their application for Oslo Cancer Cluster to become a Norwegian Centre of Expertise – the only one within health.
Already from the start, the idea was to expand the cluster from a regional Oslo-based oncology cluster to a national and international cluster. Several university hospitals and technology transfer offices from across Norway soon joined as members. Oslo Cancer Cluster today includes organisations from across the globe and the Norwegian branches of most larger pharmaceutical companies developing cancer treatments.
Opening of innovation park
In May 2015, the Oslo Cancer Cluster Innovation Park and Incubator opened at Montebello, right next to the Norwegian Radium Hospital and the Institute of Cancer Research. The Innovation Park connects the health industry with the academic milieus at the Radium Hospital Campus, gathering the entire oncology value chain in one place.
Awards and recognitions
Oslo Cancer Cluster was awarded the Gold Label certificate from the European Cluster Excellence Initiative (ECEI) in December 2019. This is the highest recognition a European cluster organisation can achieve. The certificate was renewed in December 2022, when Oslo Cancer Cluster was given an overall score of 94%.
Oslo Cancer Cluster also received Mature Cluster status within the Norwegian Innovation Clusters programme in the beginning of 2021.
Further expansions
The second building phase of Oslo Cancer Cluster Innovation Park was started in April 2023. This includes setting up a fourth section of the current building, which will house an additional 12 000 sqm of offices and laboratories for companies and public institutions working for the development of new cancer treatments.
In 2024, the architectural drawings for Oslo Science Hub were sent to Oslo City Council and the necessary lots were sold to enable construction.